The trial will enroll volunteers 18 years and older.
Preliminary results have shown Russia’s Sputnik V vaccine to be 90 percent effective in preventing COVID-19 infection, according to The Hill. Russia authorized the vaccine in August, the first country to do so. It began vaccinating people this week.
Read AstraZeneca’s full news release here.
More articles on pharmacy:
CVS targets customers in recruiting blitz ahead of COVID-19 vaccine approval
Stamford Health’s infectious diseases chair discusses health system’s COVID-19 vaccine plans
J&J cuts COVID-19 vaccine trial size due to spike in cases
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.